Predictive value of age-related acute insulin response to glucose in subjects at risk for type 1 diabetes: results of a 6-year follow-up study from west-France
- PMID: 8293864
Predictive value of age-related acute insulin response to glucose in subjects at risk for type 1 diabetes: results of a 6-year follow-up study from west-France
Erratum in
- Diabete Metab 1993 Nov-Dec;19(6):602
Abstract
The acute insulin response to i.v. glucose (AIRG) was evaluated in 344 first-degree relatives of patients with Type 1 diabetes. In 318 relatives aged 3 to 48 years without islet cell antibody and insulin autoantibody, correlations (p < 0.0006) were found between age and fasting insulinaemia, fasting glycaemia, or AIRG, with a peak during puberty. Assuming that these relatives without islet cells and insulin auto-antibodies have a low risk of developing Type 1 diabetes, we provided a "standard age-related chart" for AIRG with a "low" AIRG defined as a value below the 1st percentile for each pubertal stage. Using these cut-off points, predictive characteristics of a low AIRG for progression towards diabetes within 6 years were analysed. Four relatives developed diabetes and one displayed impaired oral glucose tolerance. Four out of these 5 subjects had islet cell and insulin auto-antibodies, but the other one was negative for these markers. Three of these 5 subjects had low AIRG at entry (30, 24 and 1 months before diabetes, respectively). The two others displayed a steady progressive decline (p < 0.02) of age-related during the follow-up before impaired oral glucose tolerance and diabetes appeared (rate of decline: 15 microU/ml/year). Thus, independently of the presence of islet cell antibodies, the predictive value of a low age-related AIRG during the follow-up is greater than the single low AIRG at entry.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
Predictive value of intravenous glucose tolerance test insulin secretion less than or greater than the first percentile in islet cell antibody positive relatives of type 1 (insulin-dependent) diabetic patients.Diabetologia. 1991 Feb;34(2):93-102. doi: 10.1007/BF00500379. Diabetologia. 1991. PMID: 2065854
-
Differential beta-cell response to glucose, glucagon, and arginine during progression to type I (insulin-dependent) diabetes mellitus.Metabolism. 1996 Mar;45(3):306-14. doi: 10.1016/s0026-0495(96)90283-8. Metabolism. 1996. PMID: 8606636
-
Relationship of beta-cell function and autoantibodies to progression and nonprogression of subclinical type 1 diabetes: follow-up of the Seattle Family Study.Diabetes. 1999 Jan;48(1):170-5. doi: 10.2337/diabetes.48.1.170. Diabetes. 1999. PMID: 9892239
-
The appropriate use of B-cell function testing in the preclinical period of type 1 diabetes.Diabet Med. 1991 Nov;8(9):800-4. doi: 10.1111/j.1464-5491.1991.tb02116.x. Diabet Med. 1991. PMID: 1837505 Review. No abstract available.
-
[Detection of subjects at risk of type 1 diabetes. GOFEDI. Groupe Ouest-France pour l'Etude du Diabète Insulino-dépendant].Rev Med Interne. 1993 Jan;14(1):25-31. doi: 10.1016/s0248-8663(05)82518-4. Rev Med Interne. 1993. PMID: 8362105 Review. French.
Cited by
-
Combined analysis of islet cell antibodies which cross-react with mouse pancreas, antibodies to the M(r) 64,000 islet protein, and antibodies to glutamate decarboxylase in subjects at risk for IDDM.Diabetologia. 1994 May;37(5):491-9. doi: 10.1007/s001250050137. Diabetologia. 1994. PMID: 8056187
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical